1. Srinakharinwirot University Institutional Repository
  2. Articles from Academic Databases : SCOPUS
  3. Scopus 1983-2021
Please use this identifier to cite or link to this item: https://ir.swu.ac.th/jspui/handle/123456789/14941
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBremner J.B.
dc.contributor.authorAmbrus J.I.
dc.contributor.authorSamosorn S.
dc.date.accessioned2021-04-05T04:32:10Z-
dc.date.available2021-04-05T04:32:10Z-
dc.date.issued2007
dc.identifier.issn9298673
dc.identifier.other2-s2.0-34250160226
dc.identifier.urihttps://ir.swu.ac.th/jspui/handle/123456789/14941-
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-34250160226&doi=10.2174%2f092986707780831168&partnerID=40&md5=4085a139fa0884a223c2597ccb7635d3
dc.description.abstractThis review collates and analyses recent work done on dual action approaches to tackling the mounting health problem of resistance by human pathogenic bacteria to antibacterial agents. In particular the areas reviewed include the use of two drugs in combination, dual action prodrugs, and dual action drugs (or hybrid drugs). © 2007 Bentham Science Publishers Ltd.
dc.subjectaminoglycoside antibiotic agent
dc.subjectamoxicillin
dc.subjectamoxicillin plus clavulanic acid
dc.subjectantiinfective agent
dc.subjectbeta lactam
dc.subjectcefamandole
dc.subjectcefotaxime
dc.subjectcephalosporin
dc.subjectchloramphenicol
dc.subjectciprofloxacin
dc.subjectclarithromycin
dc.subjectcotrimoxazole
dc.subjectcytotoxic agent
dc.subjectdalfopristin plus quinupristin
dc.subjectenrofloxacin
dc.subjecterythromycin
dc.subjectfleroxacin
dc.subjectgatifloxacin
dc.subjectmacrolide
dc.subjectmitozolomide
dc.subjectnorfloxacin
dc.subjectomeprazole
dc.subjectpenicillin G
dc.subjectprodrug
dc.subjectquinoline derived antiinfective agent
dc.subjectrifampicin
dc.subjecttemozolomide
dc.subjecttriclosan
dc.subjectunindexed drug
dc.subjectvancomycin
dc.subjectantibacterial activity
dc.subjectantibiotic resistance
dc.subjectbacterial infection
dc.subjectdrug design
dc.subjectdrug efficacy
dc.subjecthuman
dc.subjectminimum inhibitory concentration
dc.subjectnonhuman
dc.subjectrespiratory tract infection
dc.subjectreview
dc.subjectsepticemia
dc.subjectskin infection
dc.subjecturinary tract infection
dc.subjectwound infection
dc.subjectAnti-Bacterial Agents
dc.subjectBacteria
dc.subjectModels, Molecular
dc.subjectProdrugs
dc.subjectStructure-Activity Relationship
dc.titleDual action-based approaches to antibacterial agents
dc.typeReview
dc.rights.holderScopus
dc.identifier.bibliograpycitationCurrent Medicinal Chemistry. Vol 14, No.13 (2007), p.1459-1477
dc.identifier.doi10.2174/092986707780831168
Appears in Collections:Scopus 1983-2021

Files in This Item:
There are no files associated with this item.
Show simple item record


Items in SWU repository are protected by copyright, with all rights reserved, unless otherwise indicated.